` 293780 (AptaBio Therapeutics Inc) vs KOSPI 200 Comparison - Alpha Spread

A
293780
vs
K
KOSPI 200

Over the past 12 months, AptaBio Therapeutics Inc has underperformed KOSPI 200, delivering a return of +38% compared to the KOSPI 200's +83% growth.

Stocks Performance
293780 vs KOSPI 200

Loading
293780
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
293780 vs KOSPI 200

Loading
293780
KOSPI 200
Difference
www.alphaspread.com

Performance By Year
293780 vs KOSPI 200

Loading
293780
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
AptaBio Therapeutics Inc vs Peers

KOSPI 200
293780
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

AptaBio Therapeutics Inc
Glance View

Market Cap
259.4B KRW
Industry
Biotechnology

Aptabio Therapeutics, Inc. operates as a pharmaceutical biotechnology company that develops intractable innovative drugs based on original platform technology. The company is headquartered in Yongin, Gyeonggi-Do and currently employs 28 full-time employees. The company went IPO on 2019-06-12. The firm is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.

Intrinsic Value
893.51 KRW
Overvaluation 91%
Intrinsic Value
Price
A
Back to Top